A detailed history of Royal Bank Of Canada transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 203 shares of AZYO stock, worth $294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
203
Previous 203 -0.0%
Holding current value
$294
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
N/A
-36 Reduced 15.06%
203 $0
Q1 2024

Nov 05, 2024

BUY
N/A
36 Added 17.73%
239 $0
Q1 2024

May 15, 2024

BUY
N/A
129 Added 117.27%
239 $0
Q4 2023

Feb 14, 2024

BUY
$1.14 - $1.45 $2 - $2
2 Added 1.85%
110 $0
Q2 2023

Aug 14, 2023

BUY
$1.41 - $2.79 $152 - $301
108 New
108 $0
Q3 2022

Nov 14, 2022

BUY
$5.72 - $7.76 $194 - $263
34 New
34 $0
Q3 2021

Nov 15, 2021

SELL
$6.75 - $9.52 $222 - $314
-33 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.51 - $13.97 $313 - $461
33 New
33 $0

Others Institutions Holding AZYO

About AZIYO BIOLOGICS, INC.


  • Ticker AZYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,308,720
  • Market Cap $13.5M
  • Description
  • Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...
More about AZYO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.